Novus Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 06-07-2024
- Paid Up Capital ₹ 1.50 Cr
as on 06-07-2024
- Company Age 17 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.76 Cr
as on 06-07-2024
- Revenue 8.23%
(FY 2023)
- Profit 23.87%
(FY 2023)
- Ebitda -80.58%
(FY 2023)
- Net Worth 74.04%
(FY 2023)
- Total Assets 1.64%
(FY 2023)
About Novus Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.50 Cr.
The company currently has active open charges totaling ₹4.76 Cr.
Manju Saraf, Ritika Saraf, Pranav Saraf, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232MH2007PTC174821
- Company No.
174821
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Oct 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbi, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Novus Life Sciences Private Limited offer?
Novus Life Sciences Private Limited offers a wide range of products and services, including Skin Care Oil, Vitamin E Oil, Antidepressant & Anti Anxiety Medicines, Anti Anxiety Medicine, Dietary Supplements, Omega 3 Capsule, Carrier Oil, Flaxseed Oil, Vitamin Tablets & Capsules, Biotin Tablets & Capsules.
Who are the key members and board of directors at Novus Life Sciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manju Saraf  | Director | Current | |
| Ritika Saraf | Director | 09-Dec-2017 | Current |
| Pranav Saraf | Additional Director | 08-Nov-2013 | Current |
| Pramod Saraf | Director | Current |
Financial Performance of Novus Life Sciences.
Novus Life Sciences Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 8.23% increase. The company also saw a substantial improvement in profitability, with a 23.87% increase in profit. The company's net worth Soared by an impressive increase of 74.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Novus Life Sciences?
In 2023, Novus Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mahogany Holidays Private LimitedActive 11 years 6 daysRitika Saraf and Pranav Saraf are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 01 Mar 2024 | ₹2.80 Cr | Open |
Others Creation Date: 10 Aug 2023 | ₹6.60 M | Open |
Indian Bank Creation Date: 11 Sep 2013 | ₹1.30 Cr | Open |
How Many Employees Work at Novus Life Sciences?
Unlock and access historical data on people associated with Novus Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Novus Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novus Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
